Price M R, Höffken K, Baldwin R W
Transplantation. 1979 Aug;28(2):140-3. doi: 10.1097/00007890-197908000-00014.
The cytotoxicity of tumour-bearer serum against a transplanted aminoazodye-induced rat hepatoma was revealed using normal rat serum as the source of complement as assessed using a short-term 51Cr release test. The tumour-bearing rat was not deficient in a functional complement system and direct cytolysis against hepatoma cells was demonstrated following admixture of tumour cells and serum with no additional complement. No tumour growth was observed in animals receiving subcutaneous transfer of cells treated with tumour-bearer serum, although when heat-inactivated (56 C for 60 min) or normal sera were used, there was no modification of tumour development. The present findings indicate that the tumour-bearing animal contains both antibodies and complement sufficient for tumour lysis, although the full contribution of serum-mediated cytotoxicity in imposing immunological constraints upon tumour growth remains to be elucidated.
利用正常大鼠血清作为补体来源,通过短期51Cr释放试验评估,发现荷瘤大鼠血清对移植的氨基偶氮染料诱导的大鼠肝癌具有细胞毒性。荷瘤大鼠的功能性补体系统并不缺乏,在肿瘤细胞与血清混合且无额外补体的情况下,证明了对肝癌细胞的直接细胞溶解作用。接受皮下注射经荷瘤大鼠血清处理的细胞的动物未观察到肿瘤生长,然而,当使用热灭活(56℃ 60分钟)血清或正常血清时,肿瘤发展未发生改变。目前的研究结果表明,荷瘤动物同时含有足以溶解肿瘤的抗体和补体,尽管血清介导的细胞毒性对肿瘤生长施加免疫限制的全部作用仍有待阐明。